We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$252B
AUM Growth
-$7.74B
Cap. Flow
-$10.2B
Cap. Flow %
-4.03%
Top 10 Hldgs %
22.68%
Holding
10,737
New
1,370
Increased
3,710
Reduced
4,352
Closed
1,178

Sector Composition

Rank Sector Weight
1 Technology 2.53%
2 Consumer Discretionary 2.02%
3 Financials 1.63%
4 Healthcare 1.38%
5 Energy 1.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANAD
9476
DELISTED
ANADIGICS INC
ANAD
$10K ﹤0.01%
+12,948
New +$9.26K
APP
9477
PUT
DELISTED
AMERICAN APPAREL INC COM
APP
$10K ﹤0.01%
+10,100
New +$7.26K
IKAN
9478
DELISTED
IKANOS COMMUNICATIONS INC COM STK NEW (DE)
IKAN
$10K ﹤0.01%
+3,225
New +$10.7K
BLIN icon
9479
Bridgeline Digital
BLIN
$12.3M
$9K ﹤0.01%
+15
New +$11.8K
GEVO icon
9480
CALL
Gevo
GEVO
$418M
$9K ﹤0.01%
4
-5
-56% -$10.3K
IBIO icon
9481
iBio
IBIO
$73M
$9K ﹤0.01%
+3
New +$16K
NAK
9482
Northern Dynasty Minerals
NAK
$1.01B
$9K ﹤0.01%
21,319
-1,962
-8% -$807
TELL
9483
DELISTED
Tellurian Inc.
TELL
$9K ﹤0.01%
+1,303
New +$14.5K
ATL
9484
DELISTED
ATLATSA RES CORP RESOURCES CORP (F)
ATL
$9K ﹤0.01%
+49,450
New +$10.2K
IMUC
9485
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
$9K ﹤0.01%
310
-335
-52% -$9.64K
TMQ
9486
Trilogy Metals
TMQ
$663M
$8K ﹤0.01%
+16,119
New +$11K
AUMN
9487
DELISTED
Golden Minerals Company
AUMN
$8K ﹤0.01%
572
-1,742
-75% -$25K
ACUR
9488
DELISTED
Acura Pharmaceuticals
ACUR
$8K ﹤0.01%
+3,346
New +$9.26K
GPL
9489
DELISTED
Great Panther Mining Limited
GPL
$7K ﹤0.01%
1,193
-3,727
-76% -$29.3K
TRNX
9490
DELISTED
Taronis Technologies, Inc. Common Stock
TRNX
$7K ﹤0.01%
+1
New +$13.5K
ONCY
9491
CALL
DELISTED
ONCOLYTICS BIOTECH INC
ONCY
$7K ﹤0.01%
+12,900
New +$7.8K
ESCR
9492
DELISTED
ESCALERA RESOURCES CO
ESCR
$7K ﹤0.01%
14,012
-598
-4% -$704
SVRA icon
9493
CALL
Savara
SVRA
$1.15B
$6K ﹤0.01%
154
-123
-44% -$4.3K
SVRA icon
9494
Savara
SVRA
$1.15B
$6K ﹤0.01%
144
-203
-59% -$7.09K
WHLRW
9495
DELISTED
Wheeler Real Estate Investment Trust, Inc. Warrants
WHLRW
$6K ﹤0.01%
21,000
ONCY
9496
DELISTED
ONCOLYTICS BIOTECH INC
ONCY
$6K ﹤0.01%
10,471
-9,592
-48% -$5.8K
THM
9497
International Tower Hill Mines
THM
$738M
$5K ﹤0.01%
+11,349
New +$4.58K
NYMX
9498
DELISTED
Nymox Pharmaceutical Corp
NYMX
$5K ﹤0.01%
11,572
-25,916
-69% -$55.3K
NYMX
9499
PUT
DELISTED
Nymox Pharmaceutical Corp
NYMX
$5K ﹤0.01%
13,000
-29,800
-70% -$63.6K
API
9500
DELISTED
Advanced Photonix Inc
API
$4K ﹤0.01%
+12,144
New +$5.19K

Similar funds

Jeff Yass's Q4 2014 Portfolio in Review

As of Q4 2014, Jeff Yass held 10,737 positions worth $252B, down 3% from $260B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Jeff Yass withdrew a net $10.2B in Q4 2014, closing 1,178 positions and reducing 4,352 holdings. Its most notable exit was Bausch Health, an estimated $68.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.5% of assets, up from 2.2% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Jeff Yass opened a new position in Northern Trust Morningstar Global Upstream Natural Resources ETF worth $31M.

  • Jeff Yass's largest Q4 2014 buy was Northern Trust Morningstar Global Upstream Natural Resources ETF: 1,011,289 shares worth $31M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $1.22B increase.
  • Jeff Yass's biggest Q4 2014 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.37B.
  • Jeff Yass fully exited Bausch Health in Q4 2014, selling an estimated $68.9M.
  • Jeff Yass's ten largest holdings make up 23% of its $252B portfolio in Q4 2014.
  • Jeff Yass opened 1,370 new positions and closed 1,178 in Q4 2014.
  • Jeff Yass's portfolio value fell 3% quarter-over-quarter to $252B.

Based on Susquehanna International Group's 13F filing for Q4 2014, filed 17 Feb 2015.